pharmexec.com /2 weeks ago

<![CDATA[Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Prediction Markets Expose a Gap in Pharmaceutical Vendor Contracts]]>

Read source
fiercehealthcare.com /1 month ago

Beyond the Recall Notice: Why Pharmacies Need Greater Visibility Into Recalled and Expired Medications

Medication recalls and expirations are a routine part of pharmacy operations, but managing them often requires significant time, coordination and attention to detail.

Read source
pharmexec.com /2 weeks ago

<![CDATA[ANI Pharmaceuticals to Acquire Egetis Therapeutics, Egetis Sells Priority Review Voucher for $190 Million]]&...

Read source
pharmexec.com /4 weeks ago

<![CDATA[MFN Is an Offer Pharma Can’t Refuse]]>

Read source
pharmexec.com /1 week ago

<![CDATA[Pharmaceutical Executive Daily: argenx Acquires Unnatural Products Inc.]]>

Read source
pharmexec.com /6 days ago

<![CDATA[M&A Roundup: Johnson & Johnson Acquires Ollin Biosciences, Eli Lilly Acquires Calytrix Bio, AmyriAD...

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: Peptide Ruling Stalls]]>

Read source
pharmexec.com /1 month ago

<![CDATA[A Steadying Trajectory: Biopharma Review and Outlook]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive: October 2026 Interactive Digital Edition]]>

Read source
economictimes.indiatimes.com /2 weeks ago

Pills are paying off now! Pharma stocks drive 2026 rally with up to 112% returns

In 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic demand alongside enhanced profitability from...

Read source
pharmexec.com /5 days ago

<![CDATA[How Pharma Workflows Are Impacted by Agentic Models Beyond Productivity Gains]]>

Read source
pharmexec.com /3 weeks ago

<![CDATA[Roundup: Astellas Licenses IL-12 Fusion Protein From Audax in Deal Worth Up to $1.34 Billion, EVERSANA Acqui...

Read source
pharmexec.com /1 month ago

<![CDATA[ The Unique Considerations Mid-Sized Pharma Companies Face When Making MFN Deals]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>

Read source
webwire.com /3 weeks ago

KODAK PHARMACEUTICALS Expands Portfolio and Launches U.S. Online Store

Eastman Kodak Company announced the expansion of its KODAK PHARMACEUTICALS portfolio with the addition of KODAK® Normal Saline, 0.9%. The company also introduced a new U.S.-based o...

Read source
pharmexec.com /2 weeks ago

<![CDATA[The Promise of Microgravity for R&D and Manufacturing]]>

Read source
pharmexec.com /1 month ago

<![CDATA[High Value Freight in a Changing Risk Environment.]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Where Most Pharma Companies Still Have Meaningful Gaps in Their Supply Chains: LogiPharma 2026]]>

Read source
pharmexec.com /2 weeks ago

<![CDATA[Adapting Market-By-Market]]>

Read source
pharmexec.com /1 month ago

<![CDATA[Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somniver...

Read source
pharmexec.com /1 month ago

<![CDATA[Transformative Commercialization for New Biopharma Entrants: Ensuring Success With Capital and Time Efficien...

Read source
pharmexec.com /1 month ago

<![CDATA[Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Ente...

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal]]>

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Related searches